Bernd is head of the Intellectual Property department of MorphoSys AG, a German biopharmaceutical company whose key focus is on the development of novel and innovative antibodies and other biologics for the treatment of severe diseases. In his current role, Bernd is responsible for all IP matters of the organization, managing the portfolio covering MorphoSys’ antibody-related technologies and its therapeutic products. Bernd was involved in numerous corporate acquisitions, in- and out-licensing activities as well as other asset and financial transactions. He also managed a large U.S. patent litigation. Bernd also represents the organization at opposition and appeal hearings before the European Patent Office. Before entering the world of patents, Bernd worked as a microbiologist in various laboratories in Europe and Asia.